gossamer bio logo
  • About
    • Overview
    • Team
    • Management
    • Board of Directors
    • Collaboration
    • Contact
    • Locations
    • Contact Form
    • Sponsorship Disclosure
  • Seralutinib
    • About Seralutinib
    • PAH
    • PH-ILD
    • Posters & Presentations
  • Patients
    • Overview
    • Expanded Access
  • Investors
    • Overview
    • News
    • Events & Presentations
      • Events
      • Presentations
    • Filings
    • Governance
      • Overview
      • Committee Composition
      • Management
      • Board of Directors
    • Stock
      • Stock Quote & Chart
      • Historical Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • Info
      • FAQs
      • Contact IR
      • Email Alerts
  • Careers & Culture
    • Who We Are
    • Open Positions

Seralutinib for the Treatment of Pulmonary Arterial Hypertension: Results From the Phase 3 PROSERA Trial

gossamer bio logo
  • About
  • Seralutinib
  • Patients
  • Investors
  • Careers & Culture
gossamer-san-diego

USA
3115 Merryfield Row
Suite 120
San Diego, CA 92121

gossamer-dublin

Ireland
77 Sir John Rogerson’s Quay, Block C
Grand Canal Docklands
Dublin 2, D02 VK60

Follow Us

© Gossamer Bio | 2026 | Privacy Statement | Prospective Candidate Privacy Notice

logo
  • About
    • Overview
    • Team
    • Management
    • Board of Directors
    • Collaboration
    • Contact
    • Locations
    • Contact Form
    • Sponsorship Disclosure
  • Seralutinib
    • About Seralutinib
    • PAH
    • PH-ILD
    • Posters & Presentations
  • Patients
    • Overview
    • Expanded Access
  • Investors
    • Overview
    • News
    • Events & Presentations
      • Events
      • Presentations
    • Filings
    • Governance
      • Overview
      • Committee Composition
      • Management
      • Board of Directors
    • Stock
      • Stock Quote & Chart
      • Historical Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • Info
      • FAQs
      • Contact IR
      • Email Alerts
  • Careers & Culture
    • Who We Are
    • Open Positions